This is a non-core endpoint: only basic statistics are computed.
Marginal zone B-cell lymphoma
C3_MARGINAL_ZONE_LYMPHOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
397 |
4. Check minimum number of eventsNone |
397 |
5. Include endpointsNone |
397 |
6. Filter based on genotype QC (FinnGen only) |
355 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Marginal zone B-cell lymphoma
based on the number of shared cases.
Similar with more cases:
- Marginal zone B-cell lymphoma, including Hilmo
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 355 | 182 | 173 |
| Unadjusted period prevalence (%) | 0.07 | 0.06 | 0.08 |
| Median age at first event (years) | 65.55 | 63.31 | 67.91 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 369
- Matched controls
- 3690
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
307.7
309
*
XW000
NOMESCO Finland
Bone marrow biopsy
108.0
268.9
141
21
JN4BD
NOMESCO Finland
Extensive body CT
30.9
194.4
143
74
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2995.7
188.5
166
*
JN6AD
NOMESCO Finland
CT of torso and neck
108.5
162.3
84
10
H02AB02
ATC
dexamethasone; systemic
56.6
126.7
73
16
JN4AD
NOMESCO Finland
Body CT examination
14.2
114.6
124
127
A03FA01
ATC
metoclopramide; systemic, rectal
10.9
112.8
165
255
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.7
109.6
81
40
WF002
NOMESCO Finland
Radical radiotherapy
465.5
106.0
101
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
101.9
93
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
22.1
88.5
69
38
XX3DW
NOMESCO Finland
Time consuming IT work
13.8
87.0
90
84
A04AA01
ATC
ondansetron; systemic, rectal
20.2
82.7
67
40
A04AA02
ATC
granisetron; systemic, transdermal
+∞
66.7
62
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
725.1
63.9
61
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
373.8
63.5
62
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
710.9
62.7
60
*
WZC00
NOMESCO Finland
Treatment plan or consultation
5.6
61.0
202
653
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
59.0
55
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
10.9
58.8
69
76
WW500
NOMESCO Finland
Blood transfusion
21.0
55.2
43
23
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
52.4
49
*
L03AA13
ATC
pegfilgrastim; parenteral
294.9
51.5
51
*
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
51.3
48
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
559.8
50.7
49
*
ZX120
NOMESCO Finland
Intravenous
7.9
49.3
76
117
L03AA02
ATC
filgrastim; parenteral
520.4
47.4
46
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
46.9
44
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
468.9
43.1
42
*
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
42.5
40
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
41.4
39
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.3
40.1
98
235
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
78.6
37.8
42
6
M04AA01
ATC
allopurinol; systemic
4.6
37.0
111
313
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
36.0
34
*
Z51.5
ICD-10 Finland
Palliative care
7.9
35.8
53
77
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
5.3
35.1
83
192
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
32.8
31
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
11.0
32.3
36
36
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
124.5
32.2
34
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
30.6
29
*
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
+∞
30.6
29
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
9.5
29.8
37
43
130
Kela drug reimbursment
Malignant tumour
+∞
28.5
27
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
27.4
26
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
27.3
81
223
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
81.1
27.2
30
*
HA1AA
NOMESCO Finland
X-ray mammography
8.0
26.8
38
52
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
7.7
25.9
38
54
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
25.3
24
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
25.3
24
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
25.3
24
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
25.3
24
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
25.3
24
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.0
25.2
48
90
PJA10
NOMESCO Finland
Exploration of lymph nodes
75.4
25.2
28
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
267.4
25.0
25
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
24.2
23
*
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
24.2
23
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
133.7
23.9
25
*
WZC30
NOMESCO Finland
Teaching
3.8
23.5
84
263
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.6
23.4
31
39
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
23.2
22
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
23.2
22
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
43.2
23.0
28
7
WX402
NOMESCO Finland
General anaesthesia
3.3
22.9
111
422
GD1AD
NOMESCO Finland
Thorax CT examination
5.2
22.5
50
108
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.8
22.4
55
129
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
22.2
164
792
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
22.1
21
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
22.1
21
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
22.1
21
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
41.4
22.0
27
7
H02AB06
ATC
prednisolone; systemic
2.9
21.8
231
1345
R50.9
ICD-10 Finland
Fever, unspecified
3.6
21.4
83
273
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.2
21.1
29
38
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
39.8
21.1
26
7
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
20.9
124
528
1XC02, ,
NOMESCO Finland
38.2
20.1
25
7
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
20.0
19
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
20.0
19
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
77.5
19.9
22
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
77.5
19.9
22
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.2
19.8
27
35
D70.82
ICD-10 Finland
Drug-induced neutropenia
111.0
19.8
21
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.1
19.4
35
62
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
18.9
18
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
18.9
18
*
Z3231
NOMESCO Finland
Registered nurse
2.8
18.6
129
592
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.7
18.4
46
109
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
17.2
225
1393
CFA20
NOMESCO Finland
Biopsy of conjunctiva
52.7
17.2
20
*
ZX112
NOMESCO Finland
Subcutaneous
27.1
17.1
23
9
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.1
17.1
51
139
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
16.1
16.9
27
18
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
16.8
16
*
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
16.8
16
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
15.7
15
*
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
15.7
15
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.7
15
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.7
15
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
47.1
15.2
18
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.1
15.0
23
34
D70.89
ICD-10 Finland
Neutropenic splenomegaly
83.5
14.7
16
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
14.7
14
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
14.7
14
*
116
Kela drug reimbursment
Prostate cancer
+∞
14.7
14
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.7
14.4
35
81
A02BC02
ATC
pantoprazole; systemic
2.6
13.8
287
2103
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
13.6
13
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
13.6
13
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
13.6
13
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
145.1
13.5
14
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
145.1
13.5
14
*
H02AB07
ATC
prednisone; oral
2.9
13.1
73
293
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
51.9
12.9
15
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
6.3
12.7
22
37
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
25.4
12.6
17
7
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
12.6
12
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
12.6
12
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.6
12
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
12.6
12
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
12.6
12
*
CAA30
NOMESCO Finland
Biopsy of orbit
134.4
12.5
13
*
Z2221
NOMESCO Finland
Medical doctor
2.4
12.5
113
574
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
12.2
100
485
JN4CD
NOMESCO Finland
Very extensive body CT
10.6
12.2
23
23
P01BA02
ATC
hydroxychloroquine; oral
3.3
11.7
48
161
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
11.7
79
349
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
11.5
11
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
11.5
11
*
9699/3-C44.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of skin, NOS
+∞
11.5
11
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
11.5
11
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
8.8
11.5
24
29
HAB40
NOMESCO Finland
Wedge excision of mammary gland
36.3
11.3
14
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.8
11.3
21
38
B01AB05
ATC
enoxaparin; parenteral
2.2
11.2
133
753
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
11.2
50
177
TGC00
NOMESCO Finland
Bronchial lavation
5.3
11.1
23
46
N02AA05
ATC
oxycodone; systemic
2.5
11.0
79
359
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
44.7
11.0
13
*
R06AE07
ATC
cetirizine; oral
2.1
10.8
163
1008
CBA10
NOMESCO Finland
Biopsy of eyelid
29.0
10.8
14
5
ZX108
NOMESCO Finland
Inhalation
22.3
10.8
15
7
L02BG04
ATC
letrozole; oral
22.3
10.8
15
7
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
10.7
167
1047
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.8
10.6
33
92
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
10.5
10
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
10.5
10
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
10.5
10
*
1AA09, ,
NOMESCO Finland
+∞
10.5
10
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.5
10
*
L01AA02
ATC
chlorambucil; oral
+∞
10.5
10
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
10.5
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.5
10
*
A04AD12
ATC
aprepitant; systemic
+∞
10.5
10
*
A07AA02
ATC
nystatin; oral
3.6
10.4
35
103
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
11.1
10.4
19
18
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
33.6
10.4
13
*
J05AB11
ATC
valaciclovir; oral
2.5
10.4
73
328
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
10.2
57
228
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
9.9
59
244
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
56.5
9.7
11
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.4
9.5
20
25
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
9.4
9
*
A79
ICPC
Malignancy NOS
+∞
9.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
9.4
9
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
9.4
40
137
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
9.4
141
861
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.6
9.2
19
23
WX002
NOMESCO Finland
Sedation and analgesia
2.2
9.1
89
461
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
9.1
40
140
UJF32
NOMESCO Finland
Coloscopy
2.1
9.1
115
659
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
37.7
9.1
11
*
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
37.7
9.1
11
*
L02AE02
ATC
leuprorelin; implant, parenteral
51.2
8.7
10
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.0
8.7
25
66
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
28.3
8.5
11
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
8.5
120
712
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
20.6
8.5
12
6
ELB30
NOMESCO Finland
Excision of submandibular gland
20.6
8.5
12
6
B01AB10
ATC
tinzaparin; parenteral
2.8
8.5
45
175
WF099
NOMESCO Finland
Other radiotherapy
92.1
8.4
9
*
Y77
ICPC
Malignant neoplasm prostate
92.1
8.4
9
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
8.4
29
87
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
8.4
8
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
8.4
8
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
8.4
8
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
8.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.4
8
*
ZXE00
NOMESCO Finland
One hour or less
1.9
8.2
144
921
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.7
8.1
26
74
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
17.7
8.1
12
7
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
34.2
8.1
10
*
JFB00
NOMESCO Finland
Partial resection of small intestine
13.4
7.9
13
10
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.0
7.9
111
656
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
46.0
7.7
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.3
7.7
16
20
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
7.7
43
172
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
25.6
7.6
10
*
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
25.6
7.6
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
7.6
145
947
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
7.5
53
237
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
81.7
7.4
8
*
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
+∞
7.3
7
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
7.3
7
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
7.3
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.3
7
*
B02.9
ICD-10 Finland
Zoster without complication
2.8
7.2
38
147
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
30.7
7.2
9
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
20.5
7.2
10
5
J05AB01
ATC
aciclovir; systemic
2.0
7.1
92
526
WX110
NOMESCO Finland
Infiltration anesthesia
1.9
7.0
255
2011
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.9
7.0
33
120
UKC02
NOMESCO Finland
Cystoscopy
2.2
6.9
66
336
JMA10
NOMESCO Finland
Transabdominal total splenectomy
40.8
6.8
8
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
17.1
6.8
10
6
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
17.1
6.8
10
6
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.0
6.8
31
111
ZYC01
NOMESCO Finland
Remote contact by phone
3.1
6.7
29
100
ED1AA
NOMESCO Finland
Mandibular X-ray examination
23.0
6.7
9
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.7
6.7
21
59
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
71.0
6.4
7
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
71.0
6.4
7
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
71.0
6.4
7
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
71.0
6.4
7
*
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
14.6
6.4
10
7
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.4
136
909
ZXA05
NOMESCO Finland
Left side
1.9
6.4
101
616
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
11.3
6.3
11
10
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
6.3
6
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
9699/3-C50.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of breast, NOS
+∞
6.3
6
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
+∞
6.3
6
*
L02BA01
ATC
tamoxifen; oral
+∞
6.3
6
*
9699/3-C16.2
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of body of stomach
+∞
6.3
6
*
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
ZZR00
NOMESCO Finland
Flap of skin
27.2
6.3
8
*
D11.70
ICD-10 Finland
Gland sublingual
27.2
6.3
8
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.9
6.2
13
17
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.9
6.2
13
17
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
6.1
74
412
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
146
184
12.48
117.08
2.8
1.4
1.95
1.20
g/l
2.61
140
173
54
14
45.01
89.39
2.4
2.6
—
—
—
0
0
334
1681
11.40
59.82
23.0
6.0
3.63
4.29
e9/l
5.52
318
1455
305
1433
7.51
58.05
8.1
3.7
35.60
35.62
g/l
0.03
299
1335
119
261
6.25
55.07
2.3
1.6
67.28
66.88
g/l
0.19
112
238
71
96
8.92
51.49
1.7
1.4
28.90
32.64
mg/l
0.37
64
87
71
96
8.92
51.49
1.8
1.4
48.59
45.05
mg/l
0.17
63
87
65
86
8.96
47.86
1.7
1.3
2.02
1.40
ratio
1.15
46
58
57
68
9.73
45.44
2.0
1.5
—
—
—
0
0
122
323
5.15
44.81
4.1
1.8
74.37
67.61
e9/l
0.84
103
250
47
46
11.56
43.10
4.9
5.3
544.00
110.14
iu/ml
—
9
7
43
43
11.19
38.76
1.5
1.2
—
—
—
0
0
161
585
4.11
38.28
2.2
1.3
2.09
2.84
g/l
2.96
133
345
66
115
6.77
37.76
2.1
1.2
1.80
0.22
g/l
1.87
56
102
297
1683
4.92
36.37
10.3
6.1
1.22
1.21
mmol/l
0.45
267
1455
64
114
6.58
35.77
2.0
1.3
10.79
10.16
g/l
0.42
59
99
230
1114
3.83
34.86
5.9
2.1
2.36
2.36
mmol/l
0.02
220
971
39
41
10.52
33.86
3.0
1.3
33.69
32.63
pg
0.59
39
41
30
0
+∞
31.72
1.1
0.0
—
—
—
0
0
78
187
5.02
31.43
3.1
1.4
2.77
2.66
ug/l
0.12
57
138
33
5
72.19
29.43
2.5
1.6
1.06
2.38
ratio
—
33
5
35
39
9.81
29.05
1.3
1.3
152.29
178.95
au/ml
—
7
12
243
1372
3.26
25.87
22.2
10.2
0.01
0.00
e9/l
0.53
220
1125
34
45
8.22
24.61
2.4
1.7
—
—
—
0
0
240
1399
3.05
23.13
4.2
2.3
—
—
estimate
—
0
0
117
467
3.20
22.23
2.4
2.4
22.67
23.10
%
0.09
111
433
50
111
5.05
21.75
2.2
3.6
—
—
—
0
0
39
72
5.94
20.72
2.4
1.5
—
—
—
0
0
332
2436
4.62
20.11
8.5
4.6
17.83
12.35
mm/h
5.54
327
2254
29
41
7.59
19.79
1.1
1.1
283.40
307.36
u/ml
0.11
20
22
124
542
2.94
19.78
2.6
2.4
12.66
12.82
umol/l
0.07
117
500
118
503
2.98
19.68
2.4
2.3
2.25
2.27
g/l
0.20
110
461
148
723
2.75
18.99
3.8
2.0
—
—
—
0
0
52
142
4.10
17.35
3.4
1.6
1.50
1.55
g/l
0.11
47
128
246
1598
2.62
16.87
10.8
15.7
1.16
1.30
inr
5.12
209
1327
21
8
27.71
15.76
4.2
1.4
15.49
24.33
u/l
—
21
8
35
78
4.85
15.05
2.7
1.8
68.08
77.64
u/ml
0.05
30
60
34
75
4.89
14.79
2.3
1.5
—
—
—
0
0
159
886
2.40
14.66
2.6
2.2
3.04
2.88
mg/l
0.36
145
748
117
568
2.55
14.57
2.7
1.8
—
—
—
0
0
57
201
3.17
12.85
2.4
1.5
—
—
—
0
0
30
68
4.71
12.62
1.7
1.4
—
—
—
0
0
29
65
4.76
12.36
1.8
1.4
—
—
—
0
0
104
513
2.43
12.25
3.0
1.7
30.08
29.37
s
0.48
98
499
221
1488
2.21
12.23
3.2
2.5
82.73
79.19
nmol/l
0.90
215
1311
67
275
2.76
11.47
2.2
2.0
0.20
0.20
g/l
0.33
61
246
91
443
2.40
10.91
2.3
1.8
—
—
—
0
0
212
1453
2.08
10.61
3.9
2.9
261.81
124.67
ug/l
2.92
200
1342
23
30
8.10
10.55
2.7
1.6
—
—
—
0
0
22
45
5.14
10.40
1.9
1.5
—
—
—
0
0
85
412
2.38
10.24
2.3
1.8
—
—
—
0
0
100
523
2.25
10.07
2.9
3.2
2.35
2.33
e6/l
0.01
50
244
32
91
3.76
10.01
1.7
1.2
—
—
—
0
0
148
904
2.06
9.99
4.0
3.1
0.28
0.42
e6/l
0.89
109
649
21
27
8.18
9.76
2.4
1.6
—
—
—
0
0
24
56
4.51
9.73
1.8
1.4
—
—
—
0
0
24
57
4.43
9.53
1.9
1.3
—
—
—
0
0
23
55
4.39
9.05
1.3
1.3
85.97
293.91
miu/ml
—
7
23
19
39
5.08
8.93
1.1
1.1
—
—
—
0
0
16
15
11.09
8.87
4.1
1.3
—
—
—
0
0
32
99
3.44
8.85
1.4
1.2
2.44
2.19
u/ml
—
9
15
72
346
2.34
8.75
4.0
2.2
5.92
6.55
umol/l
0.38
67
308
32
101
3.37
8.58
1.4
1.2
2.39
8.86
u/ml
0.69
13
17
18
38
4.93
8.20
1.9
1.5
—
—
—
0
0
101
570
2.06
8.19
3.0
3.0
0.78
1.00
e6/l
0.46
50
294
15
16
9.72
7.85
2.4
1.1
—
—
—
0
0
15
16
9.72
7.85
2.4
1.1
—
—
—
0
0
15
16
9.72
7.85
2.4
1.1
—
—
—
0
0
15
16
9.72
7.85
2.4
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
86
3.44
7.83
2.5
2.6
0.31
0.42
iu/ml
1.16
16
48
60
279
2.37
7.82
2.8
2.1
34.37
54.41
u/l
0.60
54
222
19
30
6.62
7.82
1.5
1.8
—
—
—
0
0
12
8
15.44
7.76
2.7
1.3
—
—
—
0
0
12
8
15.44
7.76
2.7
1.1
—
—
—
0
0
12
8
15.44
7.76
2.7
1.1
—
—
—
0
0
46
197
2.53
7.15
5.5
9.4
25.31
25.16
mmol/l
0.09
46
197
19
35
5.66
7.01
2.2
1.7
—
—
—
0
0
38
153
2.65
6.68
2.7
2.1
6.88
9.22
iu/ml
0.27
17
38
11
9
12.55
6.62
1.0
1.1
—
—
—
0
0
12
13
9.50
6.33
1.3
2.6
1.83
4.04
nmol/l
1.01
12
13
45
204
2.37
6.18
1.8
1.6
—
—
—
0
0
104
647
1.85
6.14
1.8
1.7
1203.57
1186.44
nmol/l
0.07
81
501
10
8
12.80
6.11
1.4
1.6
—
—
—
0
0
111
709
1.81
5.99
1.8
1.6
1.37
1.27
mg/l
0.18
89
560
343
3063
2.70
5.98
38.0
14.8
20.96
24.40
mg/l
1.08
325
2495
16
31
5.35
5.77
2.3
1.1
—
—
—
0
0
16
31
5.35
5.77
2.3
1.1
—
—
—
0
0
16
31
5.35
5.77
2.3
1.1
—
—
—
0
0
110
719
1.75
5.42
3.9
4.2
337.87
385.22
ng/l
0.06
92
587
11
14
8.06
5.38
1.7
1.8
—
—
—
0
0
11
14
8.06
5.38
1.7
1.8
—
—
—
0
0
112
739
1.74
5.33
3.4
2.4
5.92
5.61
e6/l
0.09
104
670
30
121
2.61
5.27
2.9
1.6
—
—
—
0
0
13
22
6.08
5.27
2.1
1.6
—
—
—
0
0
22
75
3.06
5.24
3.5
2.4
1.77
1.63
mg/l
0.29
22
65
11
15
7.52
5.18
2.1
1.7
—
—
—
0
0
60
332
1.96
4.99
3.9
3.4
—
—
—
0
0
292
2510
1.78
4.85
44.3
17.8
14.23
13.63
%
8.75
292
2480
11
17
6.63
4.80
2.1
1.6
—
—
—
0
0
30
127
2.48
4.79
2.5
2.2
154.23
374.27
ug/l
2.07
30
121
215
1713
1.61
4.75
3.9
4.0
0.00
0.00
estimate
-0.00
52
329
144
1043
1.62
4.71
5.5
2.6
32.87
34.16
u/l
0.09
137
968
25
98
2.66
4.65
1.3
1.2
—
—
—
0
0
11
18
6.26
4.63
2.1
1.6
—
—
—
0
0
215
1728
1.59
4.46
4.0
4.0
0.00
0.02
estimate
0.65
50
310
211
1689
1.58
4.45
3.8
3.9
0.00
0.00
estimate
-0.00
49
319
62
361
1.86
4.42
3.9
3.1
1.45
2.03
mmol/l
0.55
57
317
335
3036
2.12
4.35
34.7
14.3
75.71
76.08
ml/min/173m2
0.13
330
2798
36
174
2.18
4.28
1.9
1.4
—
—
—
0
0
68
413
1.79
4.23
5.9
7.0
0.60
1.18
mmol/l
0.61
63
345
21
80
2.72
4.14
1.1
1.3
—
—
—
0
0
203
1630
1.55
4.08
2.7
2.6
—
—
—
0
0
22
87
2.63
4.04
1.4
1.5
0.00
0.21
iu/ml
—
5
16
204
1642
1.54
4.04
2.6
2.2
94.52
97.24
pmol/l
0.34
122
830
12
27
4.56
3.97
2.8
1.9
—
—
—
0
0
8
11
7.40
3.88
1.0
1.0
—
—
—
0
0
25
113
2.30
3.50
2.4
1.5
—
—
—
0
0
143
1097
1.50
3.38
2.1
1.7
19.74
20.23
nmol/l
0.15
128
913
14
48
2.99
3.33
1.1
1.4
—
—
—
0
0
11
28
4.02
3.31
1.0
1.0
—
—
—
0
0
6
7
8.69
3.27
2.2
1.0
—
—
—
0
0
6
7
8.69
3.27
2.2
1.0
—
—
—
0
0
12
34
3.61
3.22
1.2
1.1
—
—
—
0
0
7
11
6.46
3.20
2.0
1.2
—
—
—
0
0
7
11
6.46
3.20
2.0
1.2
—
—
—
0
0
138
1062
1.48
3.17
3.2
2.2
57.29
61.43
u/l
0.34
128
978
12
35
3.51
3.13
1.2
1.1
—
—
—
0
0
37
204
1.90
3.13
1.3
1.4
—
42.75
—
0
17
10
25
4.08
3.10
1.2
1.1
—
—
—
0
0
6
8
7.60
3.06
1.0
1.0
—
—
—
0
0
20
88
2.35
2.99
1.6
1.6
—
—
—
0
0
237
2042
1.45
2.90
3.6
3.2
52.13
47.84
u/l
0.30
224
1898
7
14
5.07
2.74
2.9
2.9
3366.57
686.86
u/ml
—
7
14
17
73
2.39
2.69
1.5
1.5
—
—
—
0
0
172
1420
1.40
2.56
3.8
4.0
21.85
74.68
ng/l
0.81
134
1083
6
12
5.06
2.41
1.2
1.2
—
—
—
0
0
18
84
2.20
2.39
2.8
1.2
—
—
—
0
0
5
8
6.32
2.38
2.2
2.3
0.61
0.58
mmol/l
—
5
8
8
22
3.69
2.37
1.0
1.0
—
—
—
0
0
7
17
4.18
2.37
1.0
1.1
—
—
—
0
0
141
1141
1.38
2.31
2.3
2.2
211.43
212.68
u/l
0.01
130
1074
37
227
1.70
2.25
2.6
2.7
78.20
19.38
au/ml
—
5
12
16
73
2.25
2.24
2.5
3.8
4.71
1.00
index
—
7
36
8
24
3.38
2.19
1.0
1.2
—
—
—
0
0
7
19
3.73
2.16
1.0
1.1
—
—
—
0
0
6
15
4.05
2.04
1.2
1.1
—
—
—
0
0
58
408
1.50
2.02
1.2
1.4
—
—
—
0
0
18
91
2.03
1.98
1.6
1.2
205.70
44.73
e6/l
—
10
73
9
33
2.77
1.94
4.2
1.1
—
—
—
0
0
6
16
3.79
1.94
1.2
1.1
—
—
—
0
0
9
34
2.69
1.87
4.2
1.1
—
—
—
0
0
9
34
2.69
1.87
4.2
1.1
—
—
—
0
0
89
689
1.38
1.86
1.3
1.3
4.65
1.76
u/ml
0.53
21
189
14
66
2.17
1.84
1.0
1.4
—
76.67
—
0
6
6
18
3.37
1.75
1.3
1.1
—
—
—
0
0
8
30
2.70
1.73
1.0
1.2
—
—
—
0
0
17
89
1.95
1.73
1.6
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
13
3.88
1.72
1.2
1.2
—
—
—
0
0
5
13
3.88
1.72
1.2
1.2
—
—
—
0
0
8
31
2.61
1.67
1.0
1.2
—
—
—
0
0
10
42
2.42
1.63
2.2
1.8
9.50
10.83
mmol/l
—
10
42
347
3332
1.69
1.62
44.7
19.9
82.63
79.49
umol/l
0.82
347
3284
8
32
2.53
1.60
1.0
1.2
—
—
—
0
0
8
32
2.53
1.60
1.0
1.2
—
—
—
0
0
31
200
1.60
1.60
6.8
3.6
1.40
2.42
mmol/l
1.03
24
150
10
44
2.31
1.57
1.5
1.1
—
85.40
—
0
5
268
2467
1.32
1.55
4.4
4.3
14.95
14.95
pmol/l
0.02
253
2236
5
15
3.36
1.53
1.4
1.1
5.30
7.38
mmol/l
—
5
15
16
86
1.90
1.53
1.4
1.2
—
—
—
0
0
16
86
1.90
1.53
1.4
1.2
—
—
—
0
0
143
1219
1.28
1.51
3.0
3.3
1808.39
1365.12
ng/l
0.57
129
1042
12
58
2.10
1.51
1.7
1.3
—
—
—
0
0
12
58
2.10
1.51
1.7
1.3
—
—
—
0
0
12
58
2.10
1.51
2.3
2.2
8.28
8.53
pmol/l
0.04
12
58
9
37
2.47
1.49
4.2
1.1
—
—
—
0
0
9
37
2.47
1.49
4.2
1.1
—
—
—
0
0
9
37
2.47
1.49
4.2
1.1
—
—
—
0
0
292
3086
0.74
1.48
6.5
7.3
38.76
40.09
mmol/mol
2.10
267
2876
5
16
3.15
1.44
3.4
1.1
41.20
39.06
g/l
—
5
16
6
24
2.52
1.31
1.7
1.1
—
—
—
0
0
6
24
2.52
1.31
1.7
1.1
—
—
—
0
0
77
618
1.31
1.27
1.4
1.3
42.75
37.53
iu/ml
0.15
28
190
8
36
2.25
1.25
1.0
1.2
—
—
—
0
0
9
45
2.02
1.24
2.7
2.4
1.23
1.20
mmol/l
—
9
45
9
45
2.02
1.24
2.7
2.4
107.22
105.60
mmol/l
—
9
45
8
37
2.19
1.22
1.1
1.1
—
1.80
—
0
8
15
86
1.78
1.21
4.2
2.2
119.13
132.44
g/l
—
8
64
8
38
2.13
1.19
1.0
1.2
—
—
—
0
0
20
126
1.62
1.17
1.4
1.3
—
—
—
0
0
8
40
2.02
1.12
4.3
2.0
0.43
1.06
mmol/l
—
8
40
112
961
1.24
1.08
4.3
4.0
0.00
0.01
estimate
0.50
48
303
346
3363
1.46
0.98
53.3
22.3
91.62
91.51
fl
0.15
346
3317
346
3364
1.46
0.96
53.8
22.5
127.82
135.55
g/l
16.18
346
3318
346
3364
1.46
0.96
54.0
22.8
38.75
40.45
%
9.47
346
3318
17
109
1.59
0.95
1.9
1.3
—
—
—
0
0
126
1418
0.83
0.92
1.9
2.0
1.33
1.31
mmol/l
0.09
104
1180
12
71
1.71
0.90
1.1
1.1
—
4.31
—
0
10
6
29
2.09
0.89
1.2
1.2
—
—
—
0
0
11
65
1.71
0.83
1.2
1.8
—
—
—
0
0
11
66
1.69
0.79
1.3
1.3
—
—
—
0
0
5
97
0.51
0.79
2.0
2.6
934.52
103.20
ug/min
—
5
55
99
866
1.20
0.78
3.6
3.5
0.07
0.00
estimate
0.49
41
257
5
24
2.10
0.75
2.0
1.7
52.20
73.03
ng/l
—
5
24
68
579
1.21
0.71
1.3
1.3
5.26
12.53
u/ml
0.98
22
214
303
3129
0.82
0.70
4.9
5.6
1.39
1.48
mmol/l
2.45
274
2875
24
179
1.36
0.69
1.3
1.2
183.31
121.87
u/ml
—
7
75
25
188
1.35
0.68
3.8
3.0
24.88
25.60
mmol/l
0.49
25
183
79
686
1.19
0.68
3.2
2.9
0.83
0.75
ug/l
0.22
54
457
307
3153
0.84
0.56
4.9
5.7
4.39
4.54
mmol/l
1.80
276
2919
69
782
0.86
0.54
4.3
4.1
1.02
1.02
kg/l
0.48
53
499
32
265
1.23
0.46
2.4
2.1
50.58
64.92
ml/min/173m2
1.28
13
106
86
779
1.14
0.44
1.7
1.8
563.09
20565593.83
pmol/l
0.73
74
637
5
31
1.62
0.43
1.2
1.1
121.80
99.81
pmol/l
—
5
31
5
31
1.62
0.43
4.6
1.6
2155.20
1397.74
mg
—
5
31
8
56
1.44
0.43
1.1
1.8
—
—
—
0
0
40
463
0.85
0.41
4.7
5.5
29.91
32.02
%
0.60
23
295
5
37
1.36
0.37
1.0
1.1
—
22.23
—
0
13
20
162
1.25
0.36
1.4
1.8
—
—
—
0
0
296
3024
0.89
0.35
4.2
4.7
1.35
1.28
mmol/l
0.72
265
2754
6
46
1.31
0.33
1.5
1.1
—
—
—
0
0
128
1209
1.09
0.31
5.6
4.4
2.39
1.95
ug/l
0.86
117
1090
34
297
1.16
0.30
1.3
1.5
—
—
—
0
0
42
378
1.13
0.26
1.4
1.5
—
—
—
0
0
316
3204
0.90
0.24
5.7
6.6
2.48
2.62
mmol/l
2.02
284
2953
128
1340
0.93
0.24
3.9
4.2
8.51
8.30
mg/mmol
0.02
76
823
5
40
1.25
0.22
1.4
1.2
6.96
7.49
mmol/l
—
5
29
5
40
1.25
0.22
2.4
4.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
6.6
—
5.79
—
0
10
48
442
1.10
0.21
7.2
6.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
10
81
1.24
0.19
1.1
1.5
—
—
—
0
0
5
69
0.72
0.17
1.0
1.2
0.83
0.86
nmol/l
—
5
54
8
69
1.16
0.16
1.3
1.4
—
—
—
0
0
131
1269
1.05
0.15
4.2
3.9
0.08
0.01
estimate
0.42
40
253
9
83
1.09
0.14
2.3
1.5
—
—
—
0
0
318
3150
1.07
0.14
5.8
5.7
5.92
6.07
mmol/l
1.62
292
2876
101
979
1.04
0.11
4.5
4.0
19.44
24.52
%
3.23
53
478
131
1334
0.97
0.07
3.1
3.4
7.12
7.35
mmol/l
0.27
104
1122
16
147
1.09
0.07
1.3
1.7
—
—
—
0
0
298
2960
1.04
0.07
5.9
5.4
2.01
1.99
mu/l
0.05
279
2692
12
132
0.91
0.06
1.1
1.0
—
—
—
0
0
17
183
0.93
0.06
1.5
1.9
3.36
3.43
mmol/l
—
10
148
25
253
0.99
0.00
1.9
2.1
3.49
3.45
ratio
0.06
19
216
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
5
58
0.86
-0.00
1.2
1.3
0.60
33.33
nmol/l
—
5
52
0
7
0.00
-0.00
0.0
1.0
—
22.89
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
0.77
—
0
7
0
8
0.00
-0.00
0.0
7.8
—
10.67
—
0
8
0
9
0.00
-0.00
0.0
1.6
—
58.88
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MARGINAL_ZONE_LYMPHOMA – Marginal zone B-cell lymphoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).